Experiences with
Venetoclax1,060 public posts
Want to take advantage of all our features? Just log in!
or
Real-world incidence and prevention of tumor lysis syndrome (TLS) in chronic lymphocytic leukemia (CLL) treated with venetoclax. From MSK
We aimed to determine the incidence of and risk factors for TLS among patients with CLL/small lymphocytic lymphoma (SLL) who received treatment with venetoclax at our institution from 1/1/2016 to 12/31/2020. We included 616 venetoclax escalations among 136 pts with CLL.
Richter's and Novel Treatments/Combinations
From the limited data available in this study, patients with prior venetoclax exposure for CLL had lower likelihood of achieving CR than those who were venetoclax naïve (13% vs 40%). Survival outcomes remained poor overall.